ATP13A2 and Parkinson disease: However, only two of the 37 PD patients with ATP13A2 mutations that we reviewed showed cation accumulation on T2∗ diffuse MRI images (Table 2), and direct postmortem pathological evidence for metal accumulation in PD is lacking [20, 33].